XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect Period of Adoption Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect Period of Adoption Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect Period of Adoption Adjustment
Balance at Dec. 29, 2017 $ 42,936   $ 414 $ 204,920   $ (1,150) $ (161,248)  
Balance (in shares) at Dec. 29, 2017     41,383          
Net income 4,968           4,968  
Other comprehensive loss (170)         (170)    
Proceeds from public offering of stock 72,150   $ 20 72,130        
Proceeds from public offering of stock (in shares)     2,000          
Common stock issued upon exercise of options 5,195   $ 6 5,189        
Common stock issued upon exercise of options (in shares)     595          
Stock-based compensation 7,399     7,399        
Repurchase of employee common stock for taxes withheld $ (54)     (54)        
Unvested restricted stock (in shares) (11)   11          
Vested restricted stock $ 2   $ 2          
Vested restricted stock (in shares)     206          
Balance at Dec. 28, 2018 132,426   $ 442 289,584   (1,320) (156,280)  
Balance (Lease Accounting Standard) at Dec. 28, 2018   $ 113           $ 113
Balance (Nonemployee Share-Based Payment Standard) at Dec. 28, 2018         $ (315)     $ 315
Balance (in shares) at Dec. 28, 2018     44,195          
Net income 14,048           14,048  
Other comprehensive loss (1,728)         (1,728)    
Common stock issued upon exercise of options 3,459   $ 4 3,455        
Common stock issued upon exercise of options (in shares)     387          
Stock-based compensation $ 11,564     11,564        
Unvested restricted stock (in shares) (11)   11          
Vested restricted stock $ 2   $ 2          
Vested restricted stock (in shares)     229          
Balance at Jan. 03, 2020 159,884   $ 448 304,288   (3,048) (141,804)  
Balance (in shares) at Jan. 03, 2020     44,822          
Net income 5,913           5,913  
Other comprehensive loss (2,497)         (2,497)    
Common stock issued upon exercise of options $ 20,646   $ 15 20,631        
Common stock issued upon exercise of options (in shares) 1,507   1,507          
Stock-based compensation $ 13,275     13,275        
Unvested restricted stock (in shares) (11)   11          
Vested restricted stock $ 1   $ 1          
Vested restricted stock (in shares)     108          
Balance at Jan. 01, 2021 $ 197,222   $ 464 $ 338,194   $ (5,545) $ (135,891)  
Balance (in shares) at Jan. 01, 2021     46,448